Mann K
Medizinische Klinik II, Klinikum Grosshadern, Universität München.
Urologe A. 1990 Mar;29(2):77-86.
In patients with testicular germ cell tumours, determination of both human chorionic gonadotropin (hCG) and alphafetoprotein (AFP) is mandatory for the diagnosis and the follow-up under treatment. Most so-called hCG-beta kits measure hCG plus the free beta-subunit. This seems to be important, as selectively elevated levels of hCG-beta have been found in some seminoma patients. Diagnosis and follow-up must always be done with the same method, because the kits available differ in specificity. AFP determination with poly- or monoclonal antibodies gives comparable results. A short-lasting increase in hCG and/or AFP during chemotherapy is due to cell necrosis and is not a sign of tumour progression. Highly elevated hCG levels at the beginning indicate a poor prognosis regardless of other parameters and should be borne in mind when decisions on treatment are made. Elevated levels of AFP mean that a pure seminoma cannot be present. In contrast, about 20% of seminoma patients have mildly elevated levels of hCG/hCG-beta, which are synthesized in syncytiotrophoblastic giant cells and only rarely in inconspicuous rounded seminoma cells. Serological hCG determinations are a more sensitive test than immunohistochemistry. The prognosis of this special form of seminoma tends to be similar to that of typical seminoma, and does not presently justify more aggressive treatment. No other highly sensitive and specific markers are available in seminoma. Nevertheless, placental alkaline phosphatase (PLAP) has some significance as a parameter for the follow-up in nonsmokers. False-positive values are found in about 20% of heavy smokers, which reduces the specificity of this test. The sensitivity is said to be about 90%. Lactate dehydrogenase (LDH) is significantly elevated, especially in the presence of advanced tumours. The specificity of LDH is low, as a variety of non-malignant diseases and minimal tissue damage can lead to pathologic serum levels. Nevertheless, LDH is of some value in the follow-up of marker-negative patients and can indicate a persistent tumour or a recurrence. Some authors have found evidence that initially elevated LDH may be an independent prognostic factor. The isoenzyme LDH 1 is easily determined, shows elevated levels in the presence of testicular germ cell tumours even if the total LDH is normal and is possibly more specific. However, the data presently available cannot yet justify its general application.(ABSTRACT TRUNCATED AT 400 WORDS)
对于睾丸生殖细胞肿瘤患者,测定人绒毛膜促性腺激素(hCG)和甲胎蛋白(AFP)对于诊断及治疗期间的随访均必不可少。大多数所谓的hCG-β试剂盒检测的是hCG加上游离β亚基。这似乎很重要,因为在一些精原细胞瘤患者中发现了hCG-β水平选择性升高的情况。诊断和随访必须始终采用相同的方法,因为现有试剂盒的特异性有所不同。使用多克隆或单克隆抗体测定AFP可得到可比的结果。化疗期间hCG和/或AFP的短暂升高是由于细胞坏死,并非肿瘤进展的迹象。开始时hCG水平高度升高表明预后不良,无论其他参数如何,在做出治疗决策时都应牢记这一点。AFP水平升高意味着不可能存在纯精原细胞瘤。相比之下,约20%的精原细胞瘤患者hCG/hCG-β水平轻度升高,其由合体滋养层巨细胞合成,在不明显的圆形精原细胞瘤细胞中很少合成。血清学hCG测定比免疫组织化学更敏感。这种特殊形式的精原细胞瘤的预后往往与典型精原细胞瘤相似,目前没有理由进行更积极的治疗。精原细胞瘤中没有其他高灵敏度和特异性的标志物。然而,胎盘碱性磷酸酶(PLAP)作为非吸烟者随访的一个参数具有一定意义。在约20%的重度吸烟者中会出现假阳性值,这降低了该检测的特异性。据说其灵敏度约为90%。乳酸脱氢酶(LDH)显著升高,尤其是在晚期肿瘤患者中。LDH的特异性较低,因为多种非恶性疾病和轻微组织损伤都可导致血清水平异常。尽管如此,LDH在标志物阴性患者的随访中具有一定价值,可提示肿瘤持续存在或复发。一些作者发现有证据表明,最初升高的LDH可能是一个独立的预后因素。同工酶LDH 1易于测定,即使总LDH正常,在睾丸生殖细胞肿瘤患者中其水平也会升高,可能更具特异性。然而,目前可得的数据尚不足以证明其可普遍应用。(摘要截选至400字)